Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetyl-GED-0507-34-Levo gel in mild to moderate facial acne vulgaris
2016-000540-33Phase 2Completed
- Sponsor
- PPM Services
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of N-acetyl-GED-0507-34-LEVO in acne vulgaris (3 arms), sponsored by PPM Services. Primary endpoint: Percentage change from baseline in inflammatory lesions at week 12. Started Apr 2016; status: completed.
02
Drugs
N-acetyl-GED-0507-34-LEVO
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2016-000540-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000540-33.